Tumor Board Review

Praise for the First Edition “As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information…by the time the book is [published]…it is outdated.” [Tumor Board Review] is fresh and just out of the oven…I haven’t seen any book in oncology like this so far…I think my investment in this book was wise and worth it.” — Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists — both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 250 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam. The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several “tumor board style” illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process. NEW TO THE SECOND EDITION OF TUMOR BOARD REVIEW: Presents the most recent guidelines and management standards in user-friendly format Focuses on current indications, use of new drugs, and new treatment of side effects Includes new FDA-approved drugs and guidelines Offers approximately 250 multiple-choice questions and answers

Tumor Board Reviews provides comprehensive coverage of all topics in oncology. Each of the 32 chapters focuses on a specific major disease. A brief overview of epidemiology and risk factors is followed by a sequence of specific presentations organized by tumors stage or disease classification. Each discussion features a case presentation that mimics the format of a tumor board presentation and thus illustrates key diagnostic and management decisions. There is also a discussion of the evidence that supports the clinical management decisions taken in the case, based on current expert panel guidelines. Algorithms and decision tree graphics are used extensively to provide visual support of the decision process. The combination of case presentations and evidence-based management discussions make this volume a unique tool for keeping current with clinical guidelines and provides the reader with a clear understanding of applications of new information for use in daily practice.

Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists--both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 350 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam. Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists--both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approvals drugs and indications. It also contains approximately 350 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam. The text continues to offer the unique combination of case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice.

Now in its 3rd edition, Tumor Board Review: Evidence-Based Case Reviews and Questions is the most comprehensive clinical case review book in the field. With hands-on input from current fellows and oncologists, this new edition has been enhanced and reformatted for greater efficiency and practicality. The review covers all disease-site areas in oncology and features a wide variety of board-style questions pivotal in helping fellows and oncologists prepare for both the ABIM medical oncology board exam and maintenance of certification (MOC) assessments. Evidence-based discussions of difficult patient cases offer an in-depth and accurate depiction of what is discussed at tumor boards and foster critical thinking essential for clinical practice. Patient cases also highlight impactful treatment decisions that include newly approved immunotherapies and targeted therapies. Each chapter contains digestible essentials for each case, including a summary of diagnosis, molecular and genomic testing, treatment options, toxicity considerations, follow-up, and survivorship. Each chapter ends with high-yield multiple-choice questions including answers and detailed rationales ensuring readers are well-equipped with the knowledge they need to make well-informed, individualized treatment decisions. Tumor Board Review: Evidence-Based Case Review and Questions is an essential case-based reference for anyone working in oncology. Key Features: Describes more than 120 patient cases, including locally advanced and metastatic cases for each major disease site Contains 300 board-style questions and answers related to case reviews Includes new advances in diagnosis and therapy, with a greater emphasis on immunotherapies, cancer genomics, and precision-based targeted therapies Provides essentials for toxicity considerations, follow-up, and survivorship considerations

Now in its third edition, Oncology Board Review: Blueprint Study Guide and Q&A is designed to help you prepare for the American Board of Internal Medicine (ABIM) Medical Oncology Certification Exam. This comprehensive digital resource has been revised to include new treatment regimens, clinical guidelines, and other advancements impacting the field as well as updated board-style Q&A. Dedicated sections cover hematological malignancies and solid tumors with a templated chapter approach highlighting epidemiology, etiology and risk factors, diagnostic criteria, staging, signs and symptoms of the disease, prognostic factors, indications for treatment, and special considerations. Later sections address other topics found on the exam, including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. With more than 240 practice questions and detailed rationales, Oncology Board Review gives you the tools to study your way and the confidence to pass the first time! Key Features: Aligns with the latest ABIM Medical Oncology Certification Exam blueprint Provides a comprehensive yet concise review of all hematologic malignancies and solid tumors Covers anticancer therapies, clinical research methodology, survivorship and palliative care, and more areas found on the exam Revised to include new treatment recommendations and FDA approvals Includes end-of-chapter assessment questions with detailed rationales - a total of more than 240 questions throughout

Tumor Board Review utilizes the knowledge and expertise of oncology specialists to enhance learning the practice of oncology. Each of the 32 chapters follows a uniform format: a concise summary of the epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of the relevant staging (generally based on the American Joint Commission on Cancer [AJCC] Staging, 7th Edition); and several Ïtumor boardÒstyleÓ illustrative patient case summaries (representative of major stage categories of each tumor), each followed by an evidence-based case discussion which reviews the current guidelines and rationale for the diagnostic and therapeutic steps taken. Algorithms and decision tree graphics are used extensively to provide visual support of the decision process. The combination of case presentations and evidence-based management discussions make this volume a unique tool for keeping current with clinical guidelines and provides the reader with a clear understanding of applications of new information for use in daily practice. The case presentations and authoritative discussions make Tumor Board Review a valuable resource for board study and self-assessment. Features of Tumor Board Review Include: Comprehensive coverage of all areas of oncology Presentation of most recent guidelines and management standards in concise, user-friendly format In-depth "tumor board" presentations showing clear clinical applications Special focus on indications and use of new drugs, and treatment of new side effects Extensive use of algorithms Color atlas section of pathology photomicrographs

Face the oncology board exam with confidence! Oncology Rapid Review, created and edited by Drs. Utkarsh H. Acharya and Tejaswini Dhawale, is a conveniently portable, effective review tool that helps you prepare for this comprehensive and challenging exam. Sturdy, full-color flash cards provide a focused, case-based review anytime, anywhere.

This volume presents the actual case studies of 157 patients who were discussed at recent tumour board conferences. The case presentations follow the structure of the tumour board conference, in which an interdisciplinary group of physicians examined a specific case, explored various treatment options, and reached a concensus on treatment. Each case presentation includes comments from physicians representing diverse specialities and treatment approaches.